Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

2 Robinhood Stocks to Sell if Joe Biden Wins the Election
2 Robinhood Stocks to Sell if Joe Biden Wins the Election

President Donald Trump and Democratic nominee Joe Biden disagree on important issues, including immigration enforcement and controlling the coronavirus pandemic. That means a change of leadership

Twilio Crushed Guidance and Estimates Again in Q3Photo, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/da273d82-9e59-413a-99b3-2b0094ff0854.png
Twilio Crushed Guidance and Estimates Again in Q3

Cloud-based communications expert Twilio (NYSE: TWLO) reported third-quarter results on the evening of Monday, October 26. The company obliterated Wall Street's expectations across the board but

President Trump Says He Prepaid His Taxes. So Do Millions of Americans by His Definition
President Trump Says He Prepaid His Taxes. So Do Millions of Americans by His Definition

Last week, during the final presidential debate with Joe Biden, President Trump responded to claims that he only paid $750 in federal income taxes for both 2016 and 2017, as per data dug up by The

Is It Too Late to Get in on This Millionaire-Maker Stock?
Is It Too Late to Get in on This Millionaire-Maker Stock?

If you had invested $50,000 in streaming entertainment giant Netflix (NASDAQ: NFLX) a decade ago, you'd be a millionaire right now. This equates to a compound annual return of approximately 35%

This 17%-Yielding Energy Stock Believes It Can Sustain Its Monster Dividend
This 17%-Yielding Energy Stock Believes It Can Sustain Its Monster Dividend

This year's downturn in the energy market has taken a growing number of dividends down with it, including several notable payouts. However, a few monster energy-fueled dividends remain intact,

Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes?
Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes?

Gilead Sciences (NASDAQ: GILD) can be both a hero and a goat, depending on your perspective as an investor. The stock price rose from $17 in July 2010 to $118 in July 2015, as the company introduced

Low Interest Rates Aren't the Biggest Problem Facing Banks
Low Interest Rates Aren't the Biggest Problem Facing Banks

The financial sector has been one of the slowest areas of the stock market to recover from the COVID-19 pandemic. While the S&P 500 is now up by 7% for the year, the financial sector is still down

Is Aurora Cannabis About to Become a Micro-Cap?
Is Aurora Cannabis About to Become a Micro-Cap?

About two years ago, Aurora Cannabis (NYSE: ACB) was considered one of the most promising marijuana companies. The pot grower was only second to Canopy Growth (NYSE: CGC) in terms of market cap at

Would Warren Buffett Buy Intuitive Surgical Stock?
Would Warren Buffett Buy Intuitive Surgical Stock?

As the maker of the da Vinci robotic surgery suite, Intuitive Surgical (NASDAQ: ISRG) doesn't fit the mold of a traditional Warren Buffett stock. The company needs to spend a significant portion of

Better Buy: Vertex Pharmaceuticals vs. Alexion PharmaceuticalsPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals

Vertex Pharmaceuticals (NASDAQ: VRTX) and Alexion Pharmaceuticals (NASDAQ: ALXN) are two major competitors in the healthcare sector, both of whom focus on developing drugs for rare diseases like

Better Buy: Illumina vs. Exelixis
Better Buy: Illumina vs. Exelixis

Comparing Illumina (NASDAQ: ILMN) with Exelixis (NASDAQ: EXEL) feels like a mismatch. The former is a dominant provider of genome sequencers serving as -- some might argue -- the foundation for the

Got $5,000? These 2 Robinhood Stocks Could Make You Rich!
Got $5,000? These 2 Robinhood Stocks Could Make You Rich!

Robinhood's trading platform is often associated with high-risk, speculative investments. And while there are arguably many bad-outlook or expensive investments on the Robinhood Top 100 list, there

Is Antitrust a Bigger Risk Than COVID-19 For Amazon Stock?Photo, wide shot, wide-angle lens,  Home appliance manufacturer, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/fb3845ac-e3c6-43ef-86c1-b57ed8c272c4.png
Is Antitrust a Bigger Risk Than COVID-19 For Amazon Stock?

COVID-19 has wreaked havoc on economies around the world and has upended many industries, including airlines, travel, and restaurants. In-store retail shopping has suffered as well, as social

3 Trendy Stocks to Buy Now
3 Trendy Stocks to Buy Now

A straightforward way of making money in the stock market is to load up on companies when they are trending up and sell them quickly when their results disappoint. Such a short-term strategy is so

Here's How Much You Should Have Saved for Retirement by Age 50
Here's How Much You Should Have Saved for Retirement by Age 50

More than half of workers 10 to 20 years from retirement (53%) say that determining how much they should save is their biggest retirement question, according to a report from the Empower Institute.

2 Fumbles and 1 Gift in Biogen's Latest Earnings Report
2 Fumbles and 1 Gift in Biogen's Latest Earnings Report

The neurology drug developer Biogen (NASDAQ: BIIB) reported its quarterly earnings on Oct. 21 , stating that its total revenue fell by 6% compared to 2019, reaching $3.37 billion for FY 2020. This

What's Next for Eli Lilly's COVID-19 Antibodies?
What's Next for Eli Lilly's COVID-19 Antibodies?

The race to develop lifesaving COVID-19 treatments recently took a surprise turn for the worse. Eli Lilly's (NYSE: LLY) COVID-19 treatment candidate, an antibody called LY-CoV555, flopped in a

Is Regeneron the Best Coronavirus Stock to Buy Today?
Is Regeneron the Best Coronavirus Stock to Buy Today?

There have now been more than 43 million confirmed cases of COVID-19 around the world, and experts are already warning of a substantial third wave of cases in many countries. It's safe to say that

This 13%-Yielding Energy Stock's Earnings Roar Higher as Volumes Bounce Back SharplyPhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
This 13%-Yielding Energy Stock's Earnings Roar Higher as Volumes Bounce Back Sharply

ONEOK's (NYSE: OKE) operational and financial results bounced back big time during the third quarter as its natural gas liquids (NGL) volumes topped their pre-pandemic level. Fueling the brisk

Here's Why Apple Paid $50 Million for an AI Video StartupPhoto, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
Here's Why Apple Paid $50 Million for an AI Video Startup

Apple (NASDAQ: AAPL) has acquired Vilynx, a company focused on using computer vision and artificial intelligence to analyze a video's audio, visual, and related text elements to understand the

This Social Security Mistake Could Leave You Dangerously Cash-Strapped
This Social Security Mistake Could Leave You Dangerously Cash-Strapped

You'll probably rely on your Social Security benefits to pay the bills in retirement. In fact, those benefits may even be your sole source of income. That's why understanding when you're allowed to

Is Northwest Biotheraputics a Buy Ahead of Its Brain Tumor Vaccine Clinical Data Release?Photo, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Is Northwest Biotheraputics a Buy Ahead of Its Brain Tumor Vaccine Clinical Data Release?

When it comes to winning biotech stocks this year, coronavirus vaccine developers automatically come to many investors' minds. However, one of the top-performing stocks in the sector is Northwest

If You Invested $10,000 in Teladoc's IPO, This Is How Much Money You'd Have Now
If You Invested $10,000 in Teladoc's IPO, This Is How Much Money You'd Have Now

The digital health sector is expected to grow with a compound annual growth rate (CAGR) of close to 30% to reach a valuation of almost $640 billion by 2026, according to market research firm

4 Top Value Stocks on Sale to Buy Right Now
4 Top Value Stocks on Sale to Buy Right Now

Investing in 2020 should really come with an instruction manual, because we've seen the stock market do things that were never believed to be possible. We witnessed the CBOE Volatility Index log its

Will Ford Stock Pop After Earnings?
Will Ford Stock Pop After Earnings?

Ford Motor Company (NYSE: F) will report its third-quarter results after the bell on Wednesday, Oct. 28. Will it outperform Wall Street's expectations? 

On average, Wall Street analysts polled by